Author

Andarz Fazlollahpour Naghibi

Observed names: A. Fazlollahpour-Naghibi, Andarz Fazlollahpour naghibi, Andarz Fazlollahpour-Naghibi, Andarz Fazlollahpour-naghibi, Fazlollahpour-Naghibi, Andarz
ORCID: 0000-0002-4743-8355
Observed ORCID: 0000-0002-4743-8355
OpenAlex ID: A5041597447
2023 · M. Farid Mojtahedi, M. Sepidarkish, et al. · Journal of Hospital Infection · 115
2024 · Ali Tavakoli Pirzaman, Mahdi Sepidarkish, et al. · EClinicalMedicine · 43
2024 · Amirreza Khalaji, Saba Mehrtabar, et al. · Therapeutic Advances in Cardiovascular Disease · 38
2023 · Farzaneh Abbasi, Mustafa Almukhtar, et al. · EClinicalMedicine · 28
2024 · Maryam Zolfaghari Dehkharghani, Safa Mousavi, et al. · IJC Heart & Vasculature · 27
2023 · Andarz Fazlollahpour-Naghibi, Kimia Bagheri, et al. · PLoS ONE · 24
2022 · Mohsen Karami Fath, Nastaran Karimfar, et al. · Cancer Cell International · 24
2023 · Andarz Fazlollahpour Naghibi, Danyal Daneshdoust, et al. · Pathology - Research and Practice · 21
2022 · Javad Setareh, Ghazale Hoseinzade, et al. · BMC Ophthalmology · 20
2024 · Amir Hossein Behnoush, Amirmohammad Khalaji, et al. · ESC Heart Failure · 19
2022 · Mohsen Karami fath, Mehran Anjomrooz, et al. · Pathology - Research and Practice · 16
2025 · Mehdi Karimi, Amir Hossein Barjasteh, et al. · Pathology - Research and Practice · 12
2025 · A. Alizadeh Khatir, A. Abbasi, et al. · Journal of Helminthology · 11
2023 · Shiva Rahimipour Anaraki, Payam Farzami, et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 7
2023 · Saeed Khalili, Fatemeh Zeinali, et al. · Cancers · 6
2025 · Andarz Fazlollahpour-naghibi, Seyed Reza Taha, et al. · Current Cancer Drug Targets · 4
2024 · Seyed Reza Taha, Andarz Fazlollahpour-Naghibi, et al. · Current Pharmaceutical Biotechnology · 4
2025 · Pouyan Ebrahimi, Hamid Parsa, et al. · Journal of Maxillofacial and Oral Surgery · 3
2025 · Mohsen Mohammadi, Nazanin Kianifard, et al. · JRSM Cardiovascular Disease · 3
2022 · Shirzad Nasiri, Seyed Mostafa Meshkati Yazd, et al. · Updates in Surgery · 2
2026 · Seyed Reza Taha, Andarz Fazlollahpour-Naghibi, et al. · Current Pharmaceutical Biotechnology
2026 · Reza Mosaddeghi-Heris, Seyyed Sina Hejazian, et al. · Anti-Cancer Agents in Medicinal Chemistry
2021 · Farrokhi, Mehrdad, Vafaei, Somayeh, et al. · Zenodo (CERN European Organization for Nuclear Research)
Works count: 24
Citation count: 455
H-index: 12
I10-index: 14
Year
Topic
Type